SenzaGen takes a first step into China – cooperates with leading expert
SenzaGen (Nasdaq First North: SENZA) has initiated a partnership with Guangzhou Chn-Alternative Biotechnology Co., Ltd (CHNALT), a leading provider of alternative, animal-free testing methods in China. The new collaboration aims to establish local networks and ensure SenzaGen with its GARD™ genome-based testing method has a strong position as China moves towards introduction of animal-free chemical testing methods. China is one of the world's largest markets, with an expected ban on animal experiments in the cosmetics industry, for example.Dr Shu-jun Cheng is the CEO of CHNALT and one of